Question

Suppose a new cancer therapy is being tested in a large clinical trial . The therapy is working well;; it seems that is extending the lives of patients suffering from a deadly form of cancer.. But the results are not yet statistically significant.. The trial is stopped so that those in the control arm be given the therapy,, under the c laim that it would not be appropriate to continue to deny them the new therapy.. The physicians directing the trial claim that stopping the trial before it provides statistically significant data might in fact delay the therapy’s wider use outside of the st udy.. Evaluate stopping the trial from a moral point of view.. Be explicit in your use of principles in your answer..   

Answer 1